Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

71 results
Display

Prediction of metabolizing enzymemediated clinical drug interactions using in vitro information

Choi S, Yim DS, Bae SH

Evaluation of drug interactions is an essential step in the new drug development process. Regulatory agencies, including U.S. Food and Drug Administrations and European Medicines Agency, have been published documents containing...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predicting human pharmacokinetics from preclinical data: volume of distribution

Yim DS, Choi S

This tutorial introduces background and methods to predict the human volume of distribution (Vd ) of drugs using in vitro and animal pharmacokinetic (PK) parameters. The physiologically based PK (PBPK)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predicting human pharmacokinetics from preclinical data: absorption

Yim DS, Choi S, Bae SH

Predicting the rate and extent of oral absorption of drugs in humans has been a challenging task for new drug researchers. This tutorial reviews in vivo and PBPK methods reported...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Potency and plasma protein binding of drugs in vitro—a potentially misleading pair for predicting in vivo efficacious concentrations in humans

Yim DS

In drug discovery or preclinical stages of development, potency parameters such as ICâ‚…â‚€, K(i), or K(d) in vitro have been routinely used to predict the parameters of efficacious exposure (AUC,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Five years of the CiPA project (2013–2018): what did we learn?

Yim DS

Cases of drug-induced QT prolongation and sudden cardiac deaths resulted in market withdrawal of many drugs and world-wide regulatory changes through accepting the ICH guidelines E14 and S7B. However, because...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Erratum: Population Pharmacokinetic Analysis of Metformin Administered as Fixed-Dose Combination in Korean Healthy Adults

Choi S, Jeon S, Han S, Yim DS

In the published version of this article, the contents of Table 1 (‘Demographic characteristics of subjects’) are incorrect.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Erratum: R-based reproduction of the estimation process hidden behind NONMEM Part 2: First-order conditional estimation

Bae KS, Yim DS

The equations on page 162 should be corrected.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans

Bae SH, Park WS, Han S, Park GJ, Lee J, Hong T, Jeon S, Yim DS

It was recently reported that the C(max) and AUC of rosuvastatin increases when it is coadministered with telmisartan and cyclosporine. Rosuvastatin is known to be a substrate of OATP1B1, OATP1B3,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development and validation of analytical method for the determination of radotinib in human plasma using liquid chromatography-tandem mass spectrometry

Seo HB, Cho S, Yoon YR, Yim DS

This study describes the development of an analytical method to determine radotinib levels in human plasma using high performance liquid chromatography (HPLC) coupled with triple quadrupole tandem mass spectrometry (MS/MS)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Principles of transparency and clinical trial registration

Yim DS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis

Kim CO, Jeon S, Han S, Hong T, Park MS, Yoon YR, Yim DS

Fimasartan is a nonpeptide angiotensin II receptor blocker. In a previous study that compared the pharmacokinetics (PK) of fimasartan between patients with hepatic impairment (cirrhosis) and healthy subjects, the exposure...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of an automated appendix generation system (ARGUS) for clinical study reports

Jang D, Han S, Yim DS

Data handling and tabulation are a time-consuming job when writing appendices for clinical study reports. The authors have developed an automated appendix generation system (ARGUS) conforming to the CDISC/SDTM standard...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hydrochlorothiazide does not increase furosemide's effects in end-stage renal disease

Huh W, Oh HY, Han JS, Jang IJ, Yim DS

Diuretic therapy for the treatment of edema in patients with end-stage renal disease (ESRD) is unsatisfactory, and a combination of thiazide and loop diuretics may produce better clinical effects. To...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tutorial for beginners: the concept of clearance explained using the example of a vacuum cleaner

Yim DS

Clearance is a key concept in pharmacokinetics, but it is not easy to understand for beginners. This tutorial aims to help beginners by using the analogy of a vacuum cleaner...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
R-based reproduction of the estimation process hidden behind NONMEM® Part 2: First-order conditional estimation

Bae KS, Yim DS

The first-order conditional estimation (FOCE) method is more complex than the first-order (FO) approximation method because it estimates the empirical Bayes estimate (EBE) for each iteration. By contrast, it is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial

Kang K, Han S, Hong T, Jeon S, Paek J, Kang JH, Yim DS

PURPOSE: A phase I clinical trial was conducted to evaluate the immunogenicity and safety of newly developed egg-cultivated trivalent inactivated split influenza vaccine (TIV) in Korea. MATERIALS AND METHODS: The TIV...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Erratum: Clearance

Holford N, Yim DS

The third equation on page 44 should be corrected.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tips for the choice of initial estimates in NONMEM

Han S, Jeon S, Yim DS

The importance of precise information and knowledge on the initial estimates (IEs) in modeling has not been paid its due attention so far. By focusing on the IE, this tutorial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Revisiting the well-stirred model of hepatic clearance: Q(H), CL(H) and F changing in the same direction

Yim DS

This tutorial examines the relationship between CL, F, and hepatic blood flow (Q(H)) quantitatively at oral and i.v. administration as an answer to the quiz set for KSCPT members. In...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Population pharmacokinetics and inter-laboratory variability of sildenafil and its metabolite after oral administration in Korean healthy male volunteers

Youn S, Park WS, Park GJ, Jang DY, Bae SH, Han S, Yim DS

This study was to clarify population pharmacokinetics (PK) of sildenafil and its metabolite, N-desmethyl sildenafil (NDS) in Korean healthy male population using a pooled data from multiple clinical trials in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr